The why and how of adaptive immune responses in ischemic cardiovascular disease. (2022)

First Author: Mallat Z
Attributed to:  Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s44161-022-00049-1

PubMed Identifier: 36382200

Publication URI: http://europepmc.org/abstract/MED/36382200

Type: Journal Article/Review

Volume: 1

Parent Publication: Nature cardiovascular research

ISSN: 2731-0590